No 03 2024

This collaboration represents a powerful alignment of capabilities designed to address the growing complexity of global regulatory requirements, the companies state.

The financing was supported by existing investors; the European Innovation Council (EIC) Fund, Lifeline Ventures, Finnish Industry Investment (TESI), and Stephen Industries Inc Oy.

The US Food and Drug Administration (FDA) has approved Aqilion's IND (investigational new drug) application for the drug candidate AQ280.

The policy prevents the NSF from awarding new research grants and from supplying allotted funds for existing grants, such as those that receive yearly increments of money.

The company has announced the successful completion of the manufacture of the first GMP drug product batch of its lead asset mitazalimab using a new improved commercial-scale manufacturing process.

The US Patent and Trademark Office (USPTO) has granted Prolight a patent for the analytical unit and reaction chamber for the company’s point-of-care analysis system, MicroFlex, which is being developed by Prolight’s partner TTP (The Technology Partnership).

Alvotech has announced that it intends to list Swedish Depository Receipts (SDRs), equity share equivalents, on Nasdaq Stockholm.